KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clearfield (CLFD) Non-Current Deffered Revenue (2016 - 2019)

Clearfield has reported Non-Current Deffered Revenue over the past 9 years, most recently at $246424.0 for Q3 2019.

  • Quarterly Non-Current Deffered Revenue fell 8.06% to $246424.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $246424.0 through Sep 2019, down 8.06% year-over-year, with the annual reading at $246424.0 for FY2019, 8.06% down from the prior year.
  • Non-Current Deffered Revenue was $246424.0 for Q3 2019 at Clearfield, down from $251759.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $281720.0 in Q3 2017 and troughed at $218085.0 in Q1 2015.
  • The 5-year median for Non-Current Deffered Revenue is $248887.0 (2017), against an average of $251912.2.
  • Year-over-year, Non-Current Deffered Revenue rose 15.58% in 2017 and then decreased 8.06% in 2019.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $233474.0 in 2015, then grew by 5.66% to $246695.0 in 2016, then increased by 13.36% to $279642.0 in 2017, then fell by 5.71% to $263661.0 in 2018, then fell by 6.54% to $246424.0 in 2019.
  • Per Business Quant, the three most recent readings for CLFD's Non-Current Deffered Revenue are $246424.0 (Q3 2019), $251759.0 (Q2 2019), and $258497.0 (Q1 2019).